Knowledge Recovery Foundation Institute
Neglected Diseases Clinical Trials Research & Drug Policy Coalition
About KRFI
KRFI was launched in 1989 by MyungHi Sonserai Lee to conserve and protect indigenous knowledge of medicinal plants for the advancement of the treatment of neglected diseases around the world.
KRFI is scientifically informed practice to policy, by evidence-based research, challenge reform, to prevent overdose deaths by prevention and Opioid Use Disorder/Substance Use Disorder (OUD/SUD) dependence with the discovery, development, and delivery of Ibogaine for addiction treatments. We have been committed to the development and research of traditional plant medicines for healing applications and has developed a Drug Master File for botanical drug for Ibogaine, and aims to develop through to the clinical trial stage.
​
KRFI develops traditional medicines and practices by securing intellectual property and land rights for the people and lands that originally provided medicine and knowledge. Biodiversity, sustainable sourcing, intellectual property protections, and access and benefit sharing are the tenets that inform our partnerships and product development. Our Research and Educational program develop the protection of the indigenous right to IP, and medical relief, in the present cultural context of the integrative health practices of entheogenic medicine.
"Licensed and taxed drug distribution systems are less violent, less expensive, and more effective than prohibition."
Support Our Mission For Global Healing
Every tax-deductible dollar contributed is donated by is dedicated to the public education and health equity in our states This allows us to pursue the important and challenging task of KRFI's mission. to advancing Ibogaine and psychedelic research and promoting policy, advocacy, education, and harm reduction programs.
Knowledge Recovery Institute is a 501(c)(3) tax exempt public charity -
Tax ID# 73-3225931. All Contributions are tax-deductible
to the extent allowable by law.​
.webp)
Our Programs
Public Education Outreach
Global Health Initiative 2030 public outreach aims to bring knowledge awareness campaign to reach the public with the purpose to collect, review, report, and publish laboratory testing results from our lab and republish data from our partnering organization's analytical data projects from worldwide.
Our goal is to bring illicit dangerous drugs' analytical report, and present safety issues of the regionally accessible drugs by individuals.
Know-Drugs.us and Know-Drugs.app aims to reach individuals with practitioners, and institutions for Opioid Use Disorder/Substance Use Disorder (OUD/SUD) treatment support. The individualized interactive guidance to the practitioners and institution engaged in OUD/SUD therapies leading in diverse healing modalities with tools and Recovery and Medical Rehabilitation.
Ibogaine & Psychedelics Clinical Trials
The Questors: Global Health Clinical Trial Management System (CTMS) works globally with CRO partners with Ibogaine use for OUD/SUD therapeutics in diverse indications. Natural Products Psychedelics (Ibogaine, 5 Meo-DMT, DMT, Psilocybin, Ayahuasca, Medical Cannabis, and other) entheogenic medicines for Addiction, Trauma and Depression aims to share the Clincial Trial Alliance in a hyperledger as a tools to advance the current scientific progress. The Questors: Global Health CTMS aims to partner Ibogaine treatments for OUD/SUD in US FDA and global Clinical Trial regulatory agencies as partnership for a regional trial.
Concepts
Global Health Initiative 2030 aims to bring partnership to the regional level through in-country coordinating mechanism (CCM) with WHO Pre-qualification Partners to join Drug Supply Chain Security Act (DSCSA) Hyperledger platform to bring Biopharmaceutical GMP security to support action to impact regional drug policy coalition with Opiate/Opioid GMP manufacturers for QA/QC, Global Mental Health Food and Drug Security Policy adaption. UNCBD has adopted Private Public Sector Partnership for Access for Benefit Sharing with diverse countries globally for ABS-IP registry. KRFI Questors ABS-IP Hyperledger Track and Trraces to accredits Bidoversity and Carbon Credits to the our offset partners for our partner at the Global Mental Health Security Fund.
Practitioner Training
KRFI in collaboration with NYS Commission for Office of Addiction Social Services (OASAS), and National Center on Addiction and Substance Abuse CASA - Columbia University, to bring clinical research partnership for practitioners in working with OUD/SUD locally with Clinical Trial Applications (CTA) protocols, and training modules for integrated lab analysis of biomarkers through the real time clinical research management and reporting, guided clinical protocol use of orescriptive mental health products for Ibogaine and psychedelic treatments as Medically Assisted Therapy (MAP).
Clinical protocol partners for health and social equity research programs of Psychedelics (Ibogaine, 5 Meo-DMT, DMT, Psilocybin, Medical Cannabis, ayahuasca and other), as entheogenic natural medicines for PTSD, Trauma and Depression for veterans, and individuals. The Questors predictive AI/ML technologies for OUD/SUD CTA MAT treatments to advance the mental health therapeutics in conplliance to HIPPA and EHRs guidelines.
Safety in
‘The Ibogaine and Psychedelic Renaissance’
We are evidence-based harm reduction organization for drug policy reform in order to bring better legal control of the prescriptive therapeutics through the Drug Supply chain distribution, cost-effective prescriptive purchase, and safety measures of therapeutics manuals for entheogenic and medical use of cannabis & psychedelic products. The Ibogaine Medically Assisted Therapy and other entheogens such as ayahuasca, psilocybin, DMT, 5- Meo DMT, Mescaline, and others are currently in scientific research for diverse indications for therapeutics applications for addiction and mental health indication. The harm reduction research are supported through our Questors global technology private public sector partnerships in building diverse GMP, GLP, GSP, GAP, GCP supply chain tracking mechanisms. Our policy advocacy aims for safety in use through legal medical accessibility and harm reduction related to its prohibition in the US policy, and drug safety regulatory model to reduce the harm, associated with criminalization, and minimize the risks to users.
Join us
Let us know how your membership and contribution can
support the impact, Discover and become part of Global Health Initiative 2030, a wellness journey.
Contact Us Info@krfi.org
Become a Member &
Discover Your Impact!
Schedule a meeting with us.
For inquiries regarding the utilization of ethnobotanicals, or in participation in research team of Drug adverse reaction research and/or access reports or difficulty integrating and experience, please read this page.​
For inquiries regarding Access for Benefit Sharing - IP Private Sector Partnership Participation, please read this page.